EXDI Exactus Inc

Exactus, Inc. Announces Participation in the Investor Summit and the Sidoti & Company Fall 2019 Conference

Exactus, Inc. Announces Participation in the Investor Summit and the Sidoti & Company Fall 2019 Conference

DELRAY BEACH, Fla., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB:EXDI) (the “Company”), a farmer and manufacturer of hemp-derived phytocannabinoid products, today announced that management will present at the Investor Summit Conference on September 17th and the Sidoti Conference on September 25th.

Investor Summit Conference in NYC – September 17th, 2019

Exactus’ President & CEO, Mr. Emiliano Aloi, and Andrew Johnson, Chief Strategy Officer, will present and hold one-on-one meetings at the in New York City on Tuesday, September 17th, 2019. The conference will take place at The Essex House, where the Company will present at 11:30 am ET.

Sidoti & Company, LLC Fall 2019 Investor Conference in NYC – September 25th, 2019

Exactus’ President & CEO, Mr. Emiliano Aloi, and Andrew Johnson, Chief Strategy Officer, will present and hold one-on-one meetings at the in New York City on Wednesday, September 25th, 2019. The conference will take place at the Grand Hyatt Hotel, where the Company will present at 1:00 pm ET.

To learn more about Exactus, Inc., visit the website at .

About Exactus:

Exactus Inc. is dedicated to introducing hemp-derived phytocannabinoid products into mainstream consumer markets. The Company has made investments in farming and has over 200 acres of CBD-rich hemp in Southwest Oregon. The Company is introducing a range of consumer brands, such as Green Goddess Extracts, Phenologie, Paradise CBD and Exactus. Hemp is a legal type of cannabis plant containing less than 0.3% THC (tetrahydrocannabinol), which is the psychoactive component of the cannabis plant. After 40 years of prohibition, the Agricultural Improvement Act of 2018, known as the 2018 Farm Bill, legalized hemp at the federal level. Hemp production will be regulated by the United States Department of Agriculture (USDA) and the states. As a result, in 2019 hemp was generally removed from the Controlled Substances Act (CSA) and enforcement by the Drug Enforcement Administration (DEA).

For more information about Exactus: .

Company Contact:

Andrew Johnson

Chief Strategy Officer

Exactus Inc.

509-999-9695



EN
11/09/2019

Underlying

EXDIExactus Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Exactus Inc

 PRESS RELEASE
Free
EXDI EXACTUS INC

Exactus, Inc. Reports Second Quarter 2020 Financial Results and Confer...

Exactus, Inc. Reports Second Quarter 2020 Financial Results and Conference Call Second Quarter 2020 Highlights Total Net Revenue of $531,240Continuation of Sales & Marketing BuildoutWhite Label Division LaunchEuropean Sales ExpansionStrengthened the Balance Sheet DELRAY BEACH, Fla., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, reported its financial results for the second quarter 2020 and conference call dial-in information. During the second quarter of 2020, Exactus c...

August 20, 2020 1 EN
 PRESS RELEASE
Free
EXDI EXACTUS INC

Exactus, Inc. Reports First Quarter 2020 Financial Results

Exactus, Inc. Reports First Quarter 2020 Financial Results First Quarter 2020 Highlights Total Net Revenue of $836,000Continuation of Sales & Marketing BuildoutRestructuring of Company and Board of DirectorsBegan Biomass Inventory Extraction ProcessDuring Q2 2020, The Company Received PPP Funds and an SBA Loan DELRAY BEACH, Fla., July 01, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, today reported financial results for the first quarter 2020. During the first quarter of 2020, E...

July 1, 2020 1 EN
 PRESS RELEASE
Free
EXDI EXACTUS INC

Exactus Appoints Leading Business Expert, Julian Pittam to Chairman of...

Exactus Appoints Leading Business Expert, Julian Pittam to Chairman of the Board of Directors DELRAY BEACH, Fla., June 15, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD) and feminized hemp genetics, announced today the appointment of executive business leader, Julian Pittam to the Chairman of the Board. “Julian Pittam has been an investor and a friendly voice of wisdom since our inception, and we are honored to have him join as Chairman of the Board at this pivotal moment,” said Emiliano Aloi, Exactus Interim Chie...

June 15, 2020 1 EN
 PRESS RELEASE
Free
EXDI EXACTUS INC

Exactus Announces its Hemp Seed Buyback Program to Assist Farmers Impa...

Exactus Announces its Hemp Seed Buyback Program to Assist Farmers Impacted by the COVID-19 Pandemic DELRAY BEACH, Fla., May 28, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD) and feminized hemp genetics, announced today the institution of its Exactus Hemp Buyback Program in support of farmers who purchase seeds from the company. Exactus introduced its buyback program during this essential hemp planting season to aid farmers faced with hardships caused by the COVID-19 pandemic. With the launch of its buyback progra...

May 28, 2020 1 EN
 PRESS RELEASE
Free
EXDI EXACTUS INC

Exactus, Inc. Reports 2019 Year End Results

Exactus, Inc. Reports 2019 Year End Results Year End 2019 Highlights Completed first harvestEntered into multiple supply agreements with industry leadersBuilt a foundation for mainstream adoptionSolidified our footprint in the hemp industryDuring Q1 2020, purchase orders for approximately $900,000 of CBD and CBG products have been received. DELRAY BEACH, Fla., May 26, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, today reported financial results for the year end 2019. Duri...

May 26, 2020 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch